U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07216846) titled 'The Geriatric Emergency Department Pharmacologic Harm Prevention Project' on Oct. 09.
Brief Summary: The goal of this project is to determine whether pharmacogenomic testing (using participants' DNA) can help optimize medication prescribing and reduce side effects in older adults taking five or more medications.
The main questions it aims to answer are:
* Can DNA-based prescribing reduce medication-related side effects, especially falls and fall-related injuries?
* Does providing pharmacogenomic results to primary care physicians improve medication safety compared with usual care?
Researchers will compare two groups:
1. DNA Car...